3/10
08:03 am
clbt
Cellebrite DI Ltd. (NASDAQ: CLBT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Low
Report
Cellebrite DI Ltd. (NASDAQ: CLBT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
3/6
10:47 am
clbt
Greenhaven Road Capital: Cellebrite (CLBT) has a Decade-Long History of Growing Quickly and Profitably [Yahoo! Finance]
Medium
Report
Greenhaven Road Capital: Cellebrite (CLBT) has a Decade-Long History of Growing Quickly and Profitably [Yahoo! Finance]
2/28
07:07 pm
clbt
SMGZY or CLBT: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
Low
Report
SMGZY or CLBT: Which Is the Better Value Stock Right Now? [Yahoo! Finance]
2/16
07:55 am
clbt
Cellebrite DI Ltd. (NASDAQ:CLBT) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]
Low
Report
Cellebrite DI Ltd. (NASDAQ:CLBT) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]
2/14
11:25 am
clbt
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Lake Street Capital from $17.00 to $26.00. They now have a "buy" rating on the stock.
Low
Report
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Lake Street Capital from $17.00 to $26.00. They now have a "buy" rating on the stock.
2/14
08:07 am
clbt
Cellebrite DI Ltd. (NASDAQ: CLBT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
Medium
Report
Cellebrite DI Ltd. (NASDAQ: CLBT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock.
2/14
02:26 am
clbt
Cellebrite DI Ltd (CLBT) Q4 2024 Earnings Call Highlights: Strong ARR Growth and Strategic ... [Yahoo! Finance]
Medium
Report
Cellebrite DI Ltd (CLBT) Q4 2024 Earnings Call Highlights: Strong ARR Growth and Strategic ... [Yahoo! Finance]
2/13
06:06 pm
clbt
Cellebrite DI Ltd. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
Medium
Report
Cellebrite DI Ltd. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
2/13
10:11 am
clbt
Cellebrite's Generative AI Innovations Deliver a Powerful Assistant to Expedite Investigations [Yahoo! Finance]
Medium
Report
Cellebrite's Generative AI Innovations Deliver a Powerful Assistant to Expedite Investigations [Yahoo! Finance]
2/13
08:11 am
clbt
Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results [Yahoo! Finance]
High
Report
Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results [Yahoo! Finance]
2/13
07:00 am
clbt
Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results
High
Report
Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results
2/12
10:24 am
clbt
Cellebrite Government Cloud Platform Achieves FedRAMP High Ready Status [Yahoo! Finance]
Low
Report
Cellebrite Government Cloud Platform Achieves FedRAMP High Ready Status [Yahoo! Finance]
2/12
08:30 am
clbt
Cellebrite Government Cloud Platform Achieves FedRAMP High Ready Status
Medium
Report
Cellebrite Government Cloud Platform Achieves FedRAMP High Ready Status
2/11
09:40 am
clbt
Value of AI, Cloud Solutions Reign in Cellebrite's 2025 Annual Industry Trends Survey [Yahoo! Finance]
Medium
Report
Value of AI, Cloud Solutions Reign in Cellebrite's 2025 Annual Industry Trends Survey [Yahoo! Finance]
2/11
09:03 am
clbt
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $24.00 to $28.00. They now have an "overweight" rating on the stock.
Medium
Report
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $24.00 to $28.00. They now have an "overweight" rating on the stock.
2/11
08:30 am
clbt
Value of AI, Cloud Solutions Reign in Cellebrite’s 2025 Annual Industry Trends Survey
Medium
Report
Value of AI, Cloud Solutions Reign in Cellebrite’s 2025 Annual Industry Trends Survey
2/6
08:30 am
clbt
Cellebrite’s Generative AI Innovations Deliver a Powerful Assistant to Expedite Investigations
Medium
Report
Cellebrite’s Generative AI Innovations Deliver a Powerful Assistant to Expedite Investigations
2/4
06:01 am
clbt
https://seekingalpha.com/article/4754555-cellebrite-country-wide-us-adoption-public-sector-remarkable [Seeking Alpha]
Low
Report
https://seekingalpha.com/article/4754555-cellebrite-country-wide-us-adoption-public-sector-remarkable [Seeking Alpha]
1/22
08:14 am
clbt
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Needham & Company LLC from $21.00 to $28.00. They now have a "buy" rating on the stock.
Low
Report
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Needham & Company LLC from $21.00 to $28.00. They now have a "buy" rating on the stock.
1/10
08:00 am
clbt
Cellebrite to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on February 13, 2025
Low
Report
Cellebrite to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on February 13, 2025
1/8
08:00 am
clbt
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference
Low
Report
Cellebrite Announces Participation in the 27th Annual Needham & Company Growth Conference
1/6
08:00 am
clbt
Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director
Low
Report
Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director
12/16
08:48 am
clbt
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $22.00 to $24.00. They now have an "overweight" rating on the stock.
Low
Report
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $22.00 to $24.00. They now have an "overweight" rating on the stock.